These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21081243)

  • 1. Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study.
    Magkos F; Brennan A; Sweeney L; Kang ES; Doweiko J; Karchmer AW; Mantzoros CS
    Metabolism; 2011 Jul; 60(7):1045-9. PubMed ID: 21081243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
    Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
    Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
    AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.
    Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
    Antivir Ther; 2003 Jun; 8(3):199-207. PubMed ID: 12924536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipokines in the HIV/HAART-associated lipodystrophy syndrome.
    Paruthi J; Gill N; Mantzoros CS
    Metabolism; 2013 Sep; 62(9):1199-205. PubMed ID: 23706880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone therapy for HIV/HAART-associated lipodystrophy syndrome could increase subcutaneous fat mass in non-lipoatrophic but not in lipoatrophic regions.
    Okada S; Konishi M; Ishii H
    BMJ Case Rep; 2016 Feb; 2016():. PubMed ID: 26917795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazolidinediones in the treatment of HIV/HAART-associated lipodystrophy syndrome.
    Edgeworth A; Treacy MP; Hurst TP
    AIDS Rev; 2013; 15(3):171-80. PubMed ID: 24002201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pioglitazone on HIV-1-related lipodystrophy: a randomized double-blind placebo-controlled trial (ANRS 113).
    Slama L; Lanoy E; Valantin MA; Bastard JP; Chermak A; Boutekatjirt A; William-Faltaos D; Billaud E; Molina JM; Capeau J; Costagliola D; Rozenbaum W
    Antivir Ther; 2008; 13(1):67-76. PubMed ID: 18389900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.
    Mulligan K; Khatami H; Schwarz JM; Sakkas GK; DePaoli AM; Tai VW; Wen MJ; Lee GA; Grunfeld C; Schambelan M
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1137-44. PubMed ID: 19174500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome.
    Sekhar RV; Jahoor F; Iyer D; Guthikonda A; Paranilam J; Elhaj F; Coraza I; Balasubramanyam A
    Metabolism; 2012 Oct; 61(10):1395-403. PubMed ID: 22542724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial.
    Hadigan C; Yawetz S; Thomas A; Havers F; Sax PE; Grinspoon S
    Ann Intern Med; 2004 May; 140(10):786-94. PubMed ID: 15148065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART).
    Schindler K; Rieger A; Tura A; Gmeinhardt B; Touzeau-Römer V; Haider D; Pacini G; Ludvik B
    Horm Metab Res; 2009 Jul; 41(7):573-9. PubMed ID: 19322744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans.
    Brennan AM; Lee JH; Tsiodras S; Chan JL; Doweiko J; Chimienti SN; Wadhwa SG; Karchmer AW; Mantzoros CS
    Eur J Endocrinol; 2009 Feb; 160(2):173-6. PubMed ID: 19029226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy.
    Addy CL; Gavrila A; Tsiodras S; Brodovicz K; Karchmer AW; Mantzoros CS
    J Clin Endocrinol Metab; 2003 Feb; 88(2):627-36. PubMed ID: 12574192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.
    Carr A; Workman C; Carey D; Rogers G; Martin A; Baker D; Wand H; Law M; Samaras K; Emery S; Cooper DA;
    Lancet; 2004 Feb; 363(9407):429-38. PubMed ID: 14962523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors.
    Santiprabhob J; Chokephaibulkit K; Khantee P; Maleesatharn A; Phonrat B; Phongsamart W; Lapphra K; Wittawatmongkol O; Rungmaitree S; Tanchaweng S; Maturapat S; Lermankul W; Tungtrongchitr R
    Cytokine; 2020 Dec; 136():155145. PubMed ID: 32920318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of postprandial nonesterified fatty acids, adipokines, and insulin across gender in human immunodeficiency virus-positive patients undergoing highly active antiretroviral therapy.
    Lu G; Thomas-Geevarghese A; Anuurad E; Raghavan S; Minolfo R; Ormsby B; Karmally W; El-Sadr WM; Albu J; Berglund L
    Metab Syndr Relat Disord; 2009 Jun; 7(3):199-204. PubMed ID: 19320559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.
    Sutinen J; Kannisto K; Korsheninnikova E; Fisher RM; Ehrenborg E; Nyman T; Virkamäki A; Funahashi T; Matsuzawa Y; Vidal H; Hamsten A; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E941-9. PubMed ID: 14749206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.